Rapid effect of mosapride citrate, 5-HT4 receptor agonist, on fasting blood glucose in Type 2 diabetes patients

Journal of Diabetes and its Complications

Volumn 23, Issue 4, 2009, Pages 255-256

  Ueno, Naohiko ^a   Satoh, Yoshiko ^a  

^a Department of Internal Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; MOSAPRIDE CITRATE; PLACEBO;

AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC DIET; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; BENZAMIDES; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MORPHOLINES; RECEPTORS, SEROTONIN, 5-HT4; TIME FACTORS; TREATMENT OUTCOME;

EID: 66949174095     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2008.01.001     Document Type: Letter

References (7)

1. Eglen R.M., Wong E.H., Dumuis A., and Bockaert J. Central 5-HT4 receptors. Trends in Pharmacological Sciences 16 (1995) 391-398
2. Forst T., Karagiannis E., Lubben G., Hohberg C., Schondorf T., Dikta G., Drexler M., Morcos M., Danschel W., Borchert M., and Pfutzner A. Pleiotrophic and anti-inflammatory effects of pioglitazone precede the metabolic activity in type 2 diabetic patients with coronary artery disease. Atherosclerosis (2007) June 21 [Epub ahead of print]
3. Horácek J., Kuzmiaková M., Höschl C., Anděl M., and Bahbonh R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology 24 (1999) 785-797
4. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
5. Ruth M., Hamelin B., Rohss K., and Lundell L. The effect of mosapride, a novel prokinetic, on acid reflux variables inpatients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 12 (1998) 35-40
6. Ueno N., Inui A., Asakawa A., Takao F., Komatsu Y., Kotani K., Nishimura R., and Kasuga M. Mosapride, a 5HT-4 receptor agonist, improves insulin sensitivity and glycaemic control in patients with Type II diabetes mellitus. Diabetologia 45 (2002) 792-797
7. 2 receptor antagonist properties. Archives Internationales de Pharmacodynmie et de Therapie 300 (1989) 51-67